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 Abstract 
Aim  
 
We have limited understanding of which risk factors contribute to increased readmission rates amongst 
people discharged from hospital with diabetes. We aim to complete the first review of its kind, to 
identify, in a systematic way, known risk factors for hospital readmission amongst people with diabetes, 
in order to better understand this costly complication. 
 
Method 
 
The review was prospectively registered in the PROSPERO database. Risk factors were identified 
through systematic review of literature in PubMed, EMBASE & SCOPUS databases, performed 
independently by two authors prior to data extraction, with quality assessment and semi-quantitative 
synthesis according to PRISMA guidelines. 
 
Results 
 
Eighty-three studies were selected for inclusion, predominantly from the United States, and utilising 
retrospective analysis of local or regional data sets. 76 distinct statistically significant risk factors were 
identified across 48 studies. The most commonly identified risk factors were; co-morbidity burden, age, 
race and insurance type. Few studies conducted power calculations; unstandardized effect sizes were 
calculated for the majority of statistically significant risk factors.  
 
Conclusion 
 
This review is important in assessing the current state of the literature and in supporting development 
of interventions to reduce readmission risk. Furthermore, it provides an important foundation for 
development of rigorous, pre-specified risk prediction models. 
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 1. Introduction 
People admitted to hospital have higher rates of diabetes than the general population. In the United 
Kingdom, 17% of inpatients have a diagnosis of diabetes mellitus [1]. Irrespective of the initial reason 
for admission, inpatients with diabetes act as a distinct cohort of patients with shared risk factors for 
adverse events [2]. People with diabetes are at a significantly increased risk of readmission following 
discharge [3, 4]. Hospital readmissions rates are a psychological and physical burden to patients, and a 
financial burden on healthcare systems [5]. Despite the importance of readmission amongst people with 
diabetes, there has been limited research in this area [6]. Specifically, no published studies have 
attempted to identify, in a systematic way, risk factors relating to readmission for this cohort of patients.  
There have been attempts to develop and validate risk prediction tools for the readmission of patients 
with diabetes. Such risk prediction tools report moderate predictive abilities [7, 8], and do not report 
using the existing research literature to rigorously pre-specify candidate variables. 
Understanding risk factors relevant to patients discharged from hospital with diabetes is important to 
patients, carers, healthcare practitioners and researchers. It supports the delivery and development of 
individualised medicine, based on each patient’s underlying risks; supports our understanding of 
regional variations in readmission risk, and supports development of evidence based interventions 
targeted at reducing readmission risks. Interestingly, the paucity of research in this area, for diabetes, is 
in direct contrast to other medical conditions, such as heart failure [9]. 
This study therefore aims to identify, systematically, known risk factors for readmission to hospital, 
among people with diabetes. The intention of the study is to cast a ‘broad net’, ascertaining all known 
risk factors, irrespective of whether identified for a specific subset of patients (such as emergency 
admissions only) or generalised populations of all inpatients with diabetes. 
This research will be essential to the planning of future diabetes services, at both an inpatient and 
community level. It will provide potential targets for improving care, reducing readmission and 
reducing costs. Identifying a comprehensive list of literature-derived risk factors further facilitates the 
development of robust pre-specified risk prediction tools. Effective risk prediction models will enable 
scarce resources to be targeted to patients with the greatest need. Overall, it is hoped that a better 
understanding of risk factors for people with diabetes will enable the development of discharge planning 
that is more effective, better patient education interventions, improved risk stratification tools and more 
targeted interventions. 
 
 
 
 
 
 
 
 
 
 
2. Methods 
The systematic review was conducted according to the PRISMA standards[10]. The study protocol was 
published in advance on the PROSPERO database (Registration Number CRD42017073773). 
2.1 Search Strategy 
A literature search was performed using PubMed, EMBASE & SCOPUS databases. The search terms 
selected were “diabetes” AND “readmission.” The search strategy included papers published between 
August 2006 and August 2018; this wide date range was to ensure that the extracted studies represented 
current clinical care practices, given historically elongated lengths of stay and differing discharge 
practices. All study designs were included, with studies limited to English language articles. Due to 
differing obstetric and paediatric care practices, articles were restricted to adult, non-obstetric patient 
cohorts. Hand searching of references was performed to identify additional studies for inclusion. 
2.2 Study Selection 
An initial review of all studies, identified by the literature search, was completed by two authors. 
Abstracts and titles were reviewed; those papers, not including information regarding risk factors for 
readmission to hospital in people with diabetes, were removed from the selected studies. Any 
discrepancies in article selection would be resolved by discussion, involving a third author. All studies 
selected after the initial screening were reviewed as full text articles, with exclusion of those that did 
not identify risk factors for readmission, did not consider diabetes, or solely considered 
diabetes as a risk factor for another condition. 
 
2.3 Data Extraction 
 
Data were extracted to a pre-piloted data collection form. The pro-forma collected information based 
on the 5 C’s (Category, Context, Correctness, Contribution and Clarity), as suggested by the engineering 
and computing research community and therefore highly relevant to research articles considering 
extraction of data from clinical information systems [11]. Additional information collected included: 
the country within which the study was conducted; whether the study was collected at a local, regional 
or national level; the extent of inpatient data sources, compared to community or social care data 
sources; the subset of patients with diabetes included in the study; risk factors that were found to be 
statistically significantly associated with readmission, alongside risk factors that were identified, but 
not tested for statistical assessment. Data were collected on the definitions of readmission used by 
different authors, in particular the time periods elapsed between admission and discharge, alongside an 
evaluation of approaches used to assess effect sizes of the risk factors identified. 
 
2.4 Quality Assessment 
 
Quality assessment for each of the selected papers was performed against pre-determined standards. 
These included an assessment of sample size, evidence to justify the sample size, appropriateness of 
any statistical tests applied, a clear description of study recruitment and assessment, with a final overall 
narrative assessment of each study’s quality. The aim of this paper is to assess the state of the literature 
regarding currently understood risk factors for readmission of people with diabetes, and thus no studies 
were excluded based on low study quality; rather a description is provided within the results section. 
 
 
2.5 Data Synthesis 
 
The diversity of definitions of readmission used in the research literature, alongside diverse subsets of 
people with diabetes in different studies, precludes any attempt at meta-analysis. Rather a narrative 
summary of risk factors identified was extracted, with subsequent thematic grouping of the risk factors 
as described below. 
 
2.6 Patient Involvement in Research 
 
This research topic was identified as an area of priority for people with diabetes. This was both through 
the Diabetes Voices Programme [12], operated by Diabetes UK, and individual patient representatives 
who were identified through NIHR People in Research [13] and reimbursed for their time contribution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3. Results 
 
3.1 Search Results 
 
The database search strategy identified 1451 articles, with an additional 10 articles identified through 
manual reference searching. Following abstract-based screening, a total of 122 articles were included 
for full text extraction and review. Forty articles were excluded following full text review, with 82 
studies remaining for full analysis. The results of the search strategy are shown in figure 1. 
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Figure 1: Flow diagram of study selection 
 
 
  
3.2 Study Characteristics 
 
From the 83 studies identified, 70 (84%) adopted a retrospective database study design, 2 articles 
described non-randomised controlled studies, with a single randomised controlled trial. There were 2 
prospective pilot studies, 3 prospective cohort studies, 2 case control study, one qualitative study, one 
systematic review and one narrative review. 
 
The majority of studies were based on patient data from the United States of America (55 studies – 
66%), with 9 studies (11%) utilising patient data from the United Kingdom. The remaining studies were 
conducted based on patient data from Denmark, Australia, Taiwan, Canada, China, Brazil, Italy, Israel, 
Japan, Saudi Arabia and Spain. One study did not clearly describe the country of origin of the patient 
population studied. 
 
Studies were predominantly conducted utilising data from a single centre (35 studies, 42%), with 18 
studies (22%) utilising data from multiple centres within a single region, and 26 studies using data from 
a national database (32%). The study setting was unclear in two studies, and not applicable to the review 
articles. Studies predominantly used inpatient electronic health record sources (68 studies, 83%), with 
5 studies (6%) utilising patient data from primary care or community sources and 9 studies (11%) using 
a combination of both community and inpatient data sources. 
 
Forty-eight studies identified statistically significant risk factors for readmission. The characteristics of 
these studies are listed in Table 1&2, 20 studies identified risk factors in generalised populations of 
patients with diabetes (Table 1) and 28 studies identified risk factors for specific sub-populations of 
patients with diabetes (Table 2). In total, 506 statistically significant risk factors were identified across 
all analysed studies, including duplicates, with a mean average of 6.10 statistically significant risk 
factors identified per study. When duplicates were removed, we collated 76 distinct risk factors for 
readmission of people with diabetes from the published literature. A full breakdown of risk factors 
identified during the data collection process is shown in Table 3. The risk factors are divided into 
whether they were identified for only a specific subpopulation of people with diabetes, or whether they 
were identified for generalised diabetes populations.  
 
From the studies identifying statistically significant risk factors there were 12 different definitions of 
readmission used, ranging from 7-days from index hospital discharge, to 5-years from index hospital 
discharge. The studies in Table 1 and 2 are ordered by this readmission definition. 
 
In addition to those risk factors found to have a statistically significant impact on research, 19 papers 
identified risk factors that had an impact on outcomes but did not reach statistical significance. This 
represented a total of 39 risk factors for readmission, 11 of which were unique and not identified in the 
list of risk factors recognised as statistically significant. These are outlined in Table 4. None of the 19 
studies, identifying these non-significant risk factors, reported a power calculation to ensure they had a 
sufficient patient population to identify significance, if present. 
 
 
 
  
3.3 Study Quality 
 
Studies typically had large sample sizes of patients, with a median average sample size of 6603 patients. 
Seven studies, however, included less than 100 participants [14-20]. All quantitative studies described 
the statistical approach taken to analysing data, and these were appropriate to the study design. One 
quantitative study did not complete any statistical significance testing [21]. Generally, there was a 
failure to pre-specify which risk factors would be assessed as primary or secondary outcomes measures, 
and thus any justification for the selection of these studies. Of central importance, only 2 studies (4%) 
described or provided the results of a power calculation, in order to justify the sample sizes used and 
relevance of the subsequent statistical tests. One study was unclear regarding their description of patient 
recruitment and subsequent patient characteristics [22].  
 
From the studies that identified statistically significant risk factors, 95% reported an effect size related 
to the risk factors identified. All effect sizes were reported using non-standardised statistical methods 
(typically Odds Ratio or Hazard Ratio), rather than standardised effect size measures (such as Cohen’s 
D or Phi). 
 
There was a single qualitative study [14], which was rigorously performed with semi-structured 
interviews and thematic analysis. It, however, was restricted to a single (urban) centre. Twenty-three 
studies were conducted only in a single centre, potentially restricting their generalisability.  
Table 1: Characteristics of studies identifying statistically significant risk factors for readmission in generalised diabetes populations (ordered by definition of readmission) 
 
Ref First author Year 
Readmission 
definition (d = 
day, m = month, 
yr = year) 
Sample 
size 
Country Study Design 
No. of variables Primary outcome 
[* =  Multiple primary or 
composite outcomes] 
Assessed Significant 
[23] X.Liu 2015 7d to >90d 37,620 China Retrospective cohort analysis 13 13 Readmission 
[24] S.Mokhtar 2012 28d 1125 Saudi Arabia Retrospective cohort & case-control  11 3 Readmission 
[25] J.Albrecht 2012 30d 26,878 USA Retrospective cohort analysis 7 7 Readmission 
[8] D.Rubin 2016 30d 44,203 USA Development & validation of risk tool 46 37 Readmission 
[26] H.Sonmez 2017 30d 102,694 USA Retrospective cohort analysis 2 2 
Readmission and 
association with admission 
diagnosis 
[27] J.Robbins 2006 30d 291,752 USA Retrospective cohort analysis 31 31 Readmission 
[28] F.Zaccardi 2017 30d 101,475 UK Retrospective case-control study 1 1 
Admission, Readmission, 
length of stay, mortality* 
[29] J.Chen 2012 30d 30,139 USA Retrospective cohort analysis 39 33 Readmission 
[18] J.Swami 2018 30d 70 USA prospective observational study 5 2 Readmission 
[30] K.Lipska 2014 30d 33,952,331 USA Retrospective observational 5 2 
Hyper/hypoglycaemia, 
hospitalization, mortality & 
readmission* 
[31] K.Bennett 2012 30d 94,121 USA Retrospective cohort analysis 24 13 Readmission 
[32] D.Rubin 2018 30d 105,791 USA Retrospective cohort analysis 43 40 Readmission 
[33] A.Karunakaran 2018 30d 17284 USA Retrospective cohort analysis 51 46 Readmission 
[34] S.Healy 2013 30d & 180d 2265 USA Retrospective cohort analysis 26 11 Readmission 
[35] X.Liu 2017 30d, 60d & 90d 73,144 China Cross sectional analysis 18 16 Readmission 
[36] L.Chwastiak 2014 1m 82,060 USA Retrospective cohort analysis 46 29 Readmission 
[37] H.Kim 2010 3m 124,967 USA Retrospective cohort analysis 32 18 
Scheduled and unscheduled 
readmissions* 
[38] J.Ena 2018 90d 1977 Spain Retrospective cohort analysis 21 10 Readmission 
[39] Y.Nishino 2015 Study period 445,504 UK Cross-sectional analysis 36 24 Admission & readmission* 
[22] S.Cramer 2010 Not declared 2633 USA Retrospective cohort analysis 10 10 Readmission 
  
 
Table 2: Characteristics of studies identifying statistically significant risk factors for specific subpopulations of people with diabetes (ordered by definition of readmission) 
Ref First author Year 
Specific diabetes 
sub-population 
Readmission 
definition (d 
= day, m = 
month, yr = 
year) 
Sample 
size 
Country Study Design 
No. of variables 
Primary outcome  
[* =  Multiple primary or composite outcomes] 
Assessed Significant 
[40] N.Wei 2013 T2DM 30d 1949 USA 
Retrospective cohort 
analysis 1 1 
Readmission & emergency department 
attendance* 
 [41] M.Engoren 2014 
Diabetes and 
CABG 30d 880 USA 
Retrospective cohort 
analysis 3 3 Readmission 
 [42] F.Lovecchio 2014 
IDDM & NIDDM 
post arthroplasty 30d 43299 USA 
Retrospective cohort 
analysis 1 1 
Medical / surgical complications & 
readmission* 
 [19] P.Lee 2014 
T2DM & Elevated 
Hba1c 90d 83 USA 
Retrospective cohort 
analysis 1 1 Readmission & emergency department visit* 
 [43] Z.Ries 2015 
Diabetes &  lower 
limb amputation 30d 439 USA 
Retrospective cohort 
analysis 20 5 Readmission 
 [44] Z.Li 2015 
Diabetes and 
CABG 30d 7348 USA 
Retrospective cohort 
analysis 1 1 Major adverse events 
 [45] A.Raval 2015 
T2DM aged over 
65 years 30d 202,496 USA 
Retrospective cohort 
analysis 37 20 Readmission 
 [46] H.Chen 2015 
Diabetes & 
ambulatory care  30d 120208 USA 
 Andersen’s 
Behavioural Model 40 17 Readmission 
 [47] D.Rubin 2017 
Cardiovascular 
disease 30d 8,189 USA 
Retrospective cohort 
analysis 43 36 Readmission 
 [48] G.Caughey 2017 Diabetes & elderly 30d 848 USA 
Retrospective cohort 
analysis 40 9 Readmission 
 [49] J.Collins 2017 T2DM 30d 63237 USA 
Development of risk 
prediction model 20 14 Readmission 
 [50] C.Holscher 2018 
Diabetic foot 
disease 30d 206 USA 
Retrospective cohort 
analysis 43 6 Readmission 
Ref First author Year 
Specific diabetes 
sub-population 
Readmission 
definition (d 
= day, m = 
month, yr = 
year) 
Sample 
size 
Country Study Design 
No. of variables 
Primary outcome  
[* =  Multiple primary or composite outcomes] 
Assessed Significant 
 [51] N.Shohat 2018 
Diabetes & 
orthopaedic 
surgery 90d 3302 USA 
Retrospective cohort 
analysis 1 1 Length of stay, readmission & mortality* 
 [52] D.Yu 2018 
T2DM and 
cardiovascular 
disease 90d 5195 UK Prospective study 16 15 Hospitalisation and rehospitalisation* 
 [53] 
H.Mochari-
Greenberger 2014 
Diabetes and 
cardiovascular 
disease 30d and 1 yr 1126 USA Prospective study 18 1 Readmission 
 [54] C.Hsieh 2015 
T2DM on 
clopidogrel 
3m, 6m & 
12m 6603 Taiwan 
Retrospective cohort 
analysis 1 1 
Acute coronary syndrome and 
revascularisation readmission* 
 [55] G.Rumenapf 2013 
Diabetic foot 
disease 1 yr 376 Germany 
Retrospective cohort 
analysis 1 1 Readmission 
 [20] L.Azevedo 2014 
Diabetic 
ketoacidosis 
admitted ITU 1 yr 76 Canada 
Retrospective 
matched cohort study 30 7 ICU admission with DKA 
 [56] P.Heaton 2016 T2DM 1 yr 13,500,000 USA 
Retrospective cohort 
analysis 17 3 Readmission 
 [57] M.Kennedy 2016 
Diabetes post 
myocardial 
infarction 2 yr 294 Netherlands Multi-modal 1 1 
Major adverse cardiovascular event, including 
readmission 
 [58] E.Wu 2012 
T2DM on insulin 
pre-admission 3 yr 2160 USA 
Observational, 
retrospective analysis  1 1 
Glycaemic control, readmission, 
hypoglycaemia,  survival & cost* 
 [59] F.Hsiao 2010 
T2DM & heart 
failure 
Study 
period 8139 Taiwan 
Retrospective cohort 
analysis 1 1 
Death, all cause readmission, first admission 
heart failure* 
 [60] M.Isidro 2013 
Diabetic 
ketoacidosis 
Study 
period 152 Spain Retrospective analysis 1 1 Multiple 
 [61] E.Wu 2012 T2DM, on insulin 
Study 
period 732 USA 
Retrospective cohort 
analysis 1 1 Hba1c, hypoglycaemia & readmission* 
 [62] M.Dhamoon 2018 Stroke 
Study 
period 25,495 Canada 
Retrospective cohort 
analysis 2 2 Mortality, recurrent stroke, readmission* 
Ref First author Year 
Specific diabetes 
sub-population 
Readmission 
definition (d 
= day, m = 
month, yr = 
year) 
Sample 
size 
Country Study Design 
No. of variables 
Primary outcome  
[* =  Multiple primary or composite outcomes] 
Assessed Significant 
 [63] M.Arguello 2018 T2DM with sepsis 
Not 
reported 395 Unknown 
Retrospective cohort 
analysis 2 1 Readmission & length of stay* 
 [64] N.Shohat 2017 
Diabetes & joint 
arthoplasty 
Not 
reported 119 USA 
Prospective cohort 
study 1 1 Surgical site infection 
 [65] F.Cosmi 2018 Heart failure 
Not 
reported 
Multiple 
studies Italy Multiple studies 1 1 Mortality & heart failure hospitalisation rate* 
  
Risk factors for specific diabetes subpopulations Risk factors identified in general diabetes population 
Risk factor Number of studies & Ref Risk factor Number of studies & Ref 
Demographic  
Age 4 [45, 46, 49, 52] Age 9 [23, 25, 29, 30, 32, 35-38] 
Race 4 [27, 46, 47, 53] Race 5 [30, 32-34, 36, 37, 39] 
Sex 4 [45, 49, 52, 62] Sex 3 [22, 37, 38] 
Marital status 2 [47, 56] Marital status 1 [32, 33] 
 
Year of discharge 1 [33] 
Language 1 [33] 
Socioeconomic status  
Insurance type 2 [47, 49] Insurance type 5 [23, 33-37] 
Education level 1 [47] Neighbourhood affluence 2 [37, 39] 
Employment status 1 [47] Urban home environment 2 [31, 37] 
 
Employment status 4 [8, 23, 32, 33, 35] 
Education level 1 [32, 33] 
Lifestyle 
Illicit substance use 2 [27, 60] Illicit substance use 3 [22, 29, 33, 36] 
Smoking status 2 [43, 50] 
  Geographic location 1 [49] 
Patient medical factors 
Co-morbidity1 5 [41, 43, 46, 49, 63] Mental illness 6 [22, 25, 29, 32, 33, 36, 37] 
Insulin dependent diabetes 2 [42, 44] Co-morbidity2 10 [22, 23, 26, 29, 32, 33, 35-38, 47] 
Macro/microvascular disease 2 [43, 46, 47, 56] Previous admission 5 [8, 32, 36, 37] 
Mental illness 2 [46, 47] Macro/microvascular disease 2 [8, 32, 33] 
Raised Body Mass Index 2 [46, 52] Hypogylcaemia admission 1 [28] 
Hypertension 2 [50, 52] Family history of diabetes 1 [35] 
Previous DKA 1 [47] Prior diabetes screening 1 [35] 
Previous admission  2 [47, 48] Disability index 1 [38] 
Cognitive impairment 1 [45] Cognitive impairment 1 [38] 
Falls 1 [45] Body mass index  1 [32, 33] 
 
Previous DKA / HHS 1 [32, 33] 
Outpatient follow up 1 [33] 
Inpatient Stay Factors 
Active case management 1 [55] Length of stay 7 [25, 32-37, 45] 
Distance from hospital 1 [47] Diabetes specific admission 1 [45] 
Surgical procedure type 1 [57] Diabetes education 2 [18, 34] 
Penalty if re-admitted 1 [46] Discharge destination 3 [25, 32, 33, 37] 
Support post-discharge 1 [46] Distance from hospital 2 [8, 32, 33] 
Cardiovascular admission 1 [48] Non-adherence to guidelines 1 [24] 
Diabetes specific admission 1 [48] Hypoglycaemia 3 [30, 37, 38, 45] 
Inpatient blood transfusion 1 [47] 
Failure to record DM 
diagnosis 1 [27] 
Enteral/parenteral nutrition 1 [47] Hospital type 2 [23, 35] 
Most extreme blood glucose  1 [47] Previous emergency care use 2 [45, 49] 
Intensive care admission 1 [47] Cardiovascular admission 1 [45] 
Glycaemic variability 1 [51] Cost of index hospitalisation 1 [35] 
Discharge care management  1 [63] Emergency admission 1 [33, 36] 
 
Inpatient blood transfusion 1 [33] 
Enteral/parenteral nutrition 1 [33] 
Diabetes inpatient consult 1 [33] 
Risk factors for specific diabetes subpopulations Risk factors identified in general diabetes population 
Risk factor Number of studies & Ref Risk factor Number of studies & Ref 
Medication related 
Combined PPI & clopidogrel 1 [54] Sulfylnourea exposure 2 [32, 37] 
Discharge on antibiotics 1 [43] 
Insulin use prior to 
admission 2 [8, 32, 33] 
Medication non-compliance 1 [27] Statin exposure 2 [29, 32, 33] 
Number of prescribers 1 [48] Insulin during admission 2 [29, 38] 
Thiazolidonide exposure 2 [47, 59] Glucocorticoid exposure 2 [32, 33, 38] 
Insulin exposure 4 [47, 58, 61, 65] Thiazolidonide exposure 1 [32, 33] 
Glucocorticoid exposure 1 [47] Antihypertensive exposure 1 [32, 33] 
Statin exposure 1 [47] Metformin exposure 1 [32, 33] 
Sulfylnourea exposure 2 [47, 56] 
 
Anti-hypertensive exposure 1 [47] 
Medication intensification 2 [19, 40] 
Speciality of physician 
prescribing anti-diabetic 
medications in community 1 [49] 
Gap in medication 
prescriptions 1 [45] 
Polypharmacy  1 [45] 
Laboratory Results  
Hba1c 2 [41, 52] Hba1c 2 [32, 34] 
Fructosamine level 1 [64] Raised haematocrit 2 [8, 32, 33] 
Electrolyte abnormalities  1 [47] Electrolyte abnormalities 3 [8, 29, 32, 33, 38] 
Serum cholesterol 1 [52] Serum Cholesterol 2 [29, 32] 
Admission elevated WBC 1 [47] Admission elevated WBC 1 [32, 33] 
Serum haematocrit 1 [47] Serum albumin 1 [33] 
Serum albumin 1 [47]   
Table 3: Statistically significant risk factors identified 
1 Specified co-morbidities: Chronic kidney disease, chronic obstructive pulmonary disease, congestive cardiac 
failure, deficiency anaemia, diseases of the heart, diseases of the urinary system, diseases of white blood cells, 
fluid and electrolyte disorders, gastrointestinal haemorrhage, haemodialysis, hypertension, liver diseases, 
obesity, other lower respiratory diseases, other nervous system disorders, pressure or stasis ulcer, respiratory 
failure, stroke, valvular disease. 
2 Specified co-morbidities: Anaemia, arrhythmia, asthma, chest pain, chronic obstructive pulmonary disease, 
coagulopathy, digestive disorders, fluid and electrolyte disorders, heart failure, hypertension, hypothyroidism, 
infection, implant, ischaemic heart disease, liver disease, lymphoma, malignant neoplasm, number of chronic 
conditions, other neurological disorders, paralysis, primary hypertension, pulmonary circulation disease, renal 
failure, rheumatoid arthritis/collagen vascular disease, stroke, valvular disease 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Additional risk factors with non-significant impact on readmission rates Article ref 
Number of primary care physicians [46] 
Living alone [46] 
Alcohol use [66] 
Failure to attend clinic appointment [66] 
Use of variable rate intravenous insulin infusion during admission [15] 
Immigration status [67] 
Elevated transaminases [43] 
Number of clinic visits [29] 
Absence of multidisciplinary team input at point of discharge [17] 
Type of beta-blocker drug [68] 
Type of community practice [49] 
Body mass index [47] 
SGLT2 exposure [69] 
Insulin type [70] 
Table 4: Additional risk factors with non-significant impact on readmission rate 
 
 
 
 
 
 
 
4. Discussion 
 
Reducing readmission risk following hospital discharge, is a key priority for patients and policy makers 
across healthcare systems. People with diabetes are at an increased risk of hospital readmission. This 
article represents the first review of its kind, aiming to identify, in a systematic way, risk factors for 
readmission to hospital, amongst both generalised and specific populations of people with diabetes. A 
total of 76 distinct statistically significant risk factors were identified, with the most commonly 
identified being co-morbidities (16 studies), age (13 studies), race (10 studies), insurance type (8 
studies), sex (7 studies). A requirement for insulin was a widely reported risk factor either before 
admission, during admission or subsequent to discharge. 
  
The research remains at a relatively early stage of maturity, with the majority of studies representing 
retrospective reviews of local or regional datasets. The research is dominated by studies from the USA, 
which itself has a unique insurance-based approach to healthcare, and thus may not be representative 
of readmission patterns in other countries. 
 
There were only two review articles that considered risk factors for readmission, one study was for a 
particularly specific subset of patients following cardiac surgery [71], and the other a narrative review 
article considering generalised diabetes readmission and preventions opportunities [6]. One study took 
a qualitative approach to data collection [14]. Given the nature of diabetes, as a disease of self-
management, it is important that we gain a greater qualitative understanding of factors affecting 
readmission. The absence of qualitative studies may explain the relative paucity of psychological and 
patient-educational factors in the list of statistically significant risk factors extracted into Table 2.  
 
The methodological and statistical approaches, to identifying risk factors, are also at an early stage of 
maturity. Whilst studies have relatively large sample sizes, there was rarely any attempt to identify the 
required sample sizes to meet significance testing through appropriate power calculations. This may 
explain the relatively low average number of statistically significant risk factors identified per study. It 
is a particular concern that, this approach to statistical planning for studies may mean that a number of 
risk factors, which could be statistically significant, were an appropriate sample size was selected, could 
have been missed. Conversely, the significant risk factors identified in Table 1 & 2 include those based 
on univariate comparisons, and it is important to note that univariate significance may disappear after 
adjustment for confounders in multivariable modelling. We have included risk factors identified 
through univariate comparison in order to provide a comprehensive overview of the current literature. 
 
The underlying variation in the patient populations described (both in the generalised patient 
populations and specific patient populations), alongside significant variation in the definition of 
readmission and use of unstandardized effect size statistical tools, precludes a meaningful quantitative 
meta-analysis of the effect sizes described, in order to create a “hierarchy” of risk factors, or to assess 
the consistency across studies identifying the same risk factors. The further comprehensive, quantitative 
evaluation of risk factors, in properly powered multi-centre studies will be essential to better 
understanding and modifying the risk factors, most relevant to patients diagnosed from hospital with 
diabetes. 
 
The risk factors acknowledged in this review, demonstrate a truly diverse set of factors that significantly 
contribute to readmission risks in patients with diabetes. Interestingly, relatively little overlap exists 
between studies, with 29 risk factors (38%) being identified in just one study. Risk factors are relatively 
evenly distributed across the demographic, socio-economic, lifestyle, patient medical, medication 
related and pathology result categories described above. Forty-one percent of risk factors (31 risk 
factors) were identified in both studies examining a subset of populations with diabetes, and those 
identifying risk factors for generalised populations of patients with diabetes. This overlap potentially 
raises the argument that people with diabetes can be treated as a distinct population within the inpatient 
setting.  
 
This study has a number of strengths including pre-registration in PROSPERO; a clearly defined, two-
person search across three databases; assessment of study quality; semi-quantitative data synthesis; and 
patient and public involvement demonstrating the research question as a priority for patients. There are, 
however, a number of limitations that should be considered, including the fact that the study only 
considers English Language papers. There is also a potential limitation in the grouping of risk factors 
identified as statistically significant in Table 2; for example, mental health diagnoses have been grouped 
separately, whilst some might argue they could be considered together. The groupings have, however, 
been decided across the research team, and individualised references provided to support future 
researchers. 
 
This study identifies a number of key research priorities to better support patients at discharge from 
hospital with diabetes. Many of the studies reported mortality outcomes following discharge alongside 
readmission outcomes, and it will be important to assess the extent to which the research literature has 
considered mortality outcomes, given a lack of systematic review in this area. Similarly, the inability to 
perform a quantitative meta-analysis of effect sizes, related to individual risk factors identified, 
demonstrates and important gap in the research literature.  
 
Taken together, the literature demonstrates that risk factors can, and have been identified for people 
with diabetes, being readmitted to hospital. This is a valuable resource to patients, clinicians and 
academics looking to improve the process of inpatient discharge from hospital. There is a clear need for 
statistically rigorous studies, which incorporate data from both inpatient, community and qualitative 
sources to understand further these diverse risk factors, matched to meaningful effect sizes, to be 
developed. Such research would act as the foundation for both cohorting at risk patient populations and 
introducing targeted personalised interventions, in order to improve the quality of care for provided for 
people with diabetes. 
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